WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009623) REGULATION OF HUMAN RECEPTOR-INTERACTING SERINE-THREONINE KINASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009623    International Application No.:    PCT/EP2003/007959
Publication Date: 29.01.2004 International Filing Date: 22.07.2003
IPC:
C12N 9/12 (2006.01)
Applicants: BAYER HEALTHCARE AG [DE/DE]; 51368 Leverkusen (DE) (For All Designated States Except US).
LIOU, Jiing-Ren [CN/US]; (US) (For US Only)
Inventors: LIOU, Jiing-Ren; (US)
Common
Representative:
BAYER HEALTHCARE AG; 51368 Leverkusen (DE)
Priority Data:
60/397,574 23.07.2002 US
60/432,657 12.12.2002 US
Title (EN) REGULATION OF HUMAN RECEPTOR-INTERACTING SERINE-THREONINE KINASE
(FR) REGULATION DE LA SERINE-THREONINE KINASE INTERAGISSANT AVEC DES RECEPTEURS HUMAINS
Abstract: front page image
(EN)Reagents that regulate human receptor-interacting serine-threonine kinase and reagents which bind to human receptor-interacting serine-threonine kinase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, diabetes and other metabolic disorders, neurological disorders, cardiovascular disorders, endocrine and hormonal disorders, inflammatory disorders, gastrointestinal and liver disorders, hematological disorders, respiratory disorders, reproductive disorders, and genitourinary disorders.
(FR)L'invention concerne des réactifs qui régulent la sérine-thréonine kinase interagissant avec des récepteurs humains et des réactifs qui se lient à des produits géniques de la sérine-thréonine kinase interagissant avec des récepteurs humains pouvant jouer un rôle dans la prévention, l'amélioration ou le traitement de dysfonctionnements ou de maladies, notamment, le cancer, le diabète et d'autres troubles métaboliques, et des troubles neurologiques, cardio-vasculaires, endocrinaux et hormonaux, inflammatoires, gastro-intestinaux et hépatiques, hématologiques, respiratoires, de la reproduction et génito-urinaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)